How Big is the Theranostics Market | Industry Trends & Analysis 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA9333

Publication Date: Sep 2025

How Big is the Theranostics Market?

According to 6Wresearch internal database and industry insights, the Global Theranostics Market was valued at USD 4.5 Billion in 2024 and is expected to reach USD 8.2 Billion by 2031, growing at a compound annual growth rate of 8.30% during the forecast period (2025-2031).

The drivers of the market expansion are the rising prevalence of chronic illnesses, the expanding use of personalized medicine, advancements in diagnostic and therapeutic technologies, and programs to promote precision healthcare.

View Main Report

Schedule Analyst Call

Key Growth Drivers of the Theranostics Market

Rising demand for personalized and precision medicine solutions
Technological advancements in molecular imaging and targeted therapy
Increasing investments in oncology and chronic disease research
Growing adoption of companion diagnostics in clinical practice
Expansion of nuclear medicine and radiopharmaceutical applications

Theranostics Market Trends

Theranostics Market is witnessing notable growth with trends such as integration of diagnostics with targeted therapeutics, increasing use of PET and SPECT imaging, and development of radio labelled drugs for cancer treatment. Demand for non-invasive and accurate diagnostic methods is rising. Adoption of AI and machine learning for patient stratification is increasing. Market is observing collaborations between pharmaceutical and biotech companies. There is a growing focus on theranostic agents for neurodegenerative diseases and cardiovascular conditions. Personalized monitoring and treatment planning are becoming more popular. Regulatory structures are changing to facilitate theranostic product approvals more quickly.

Emerging Developments in the Theranostics Market

Theranostics Market is evolving with advancements in radiopharmaceuticals, nanotheranostics, and targeted therapies. Research and development is still going on for new molecular probes and imaging agents. Innovations are being aided by increased partnerships between pharmaceutical companies and research institutes. Hospital-based theranostic facility expansion is fueling market expansion. The advancement of multimodal imaging methods is being given top priority. Platforms for precision medicine and AI-driven diagnostics are seeing an increase in investment. Product development is being driven by an emphasis on improving patient outcomes and minimizing side effects. The market landscape is being shaped by technological integration for real-time and personalized monitoring.